AARD
Aardvark Therapeutics, Inc. Common Stock
There isn't enough reported data to score AARD yet.
AARD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
AARD's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
AARD PE Valuation
AARD has no meaningful PE right now: it lost money over the past year.
AARD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect AARD's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
AARD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.21 | -$1.24 |
| Q1 2026 | -$3.21 | -$1.65 |
| Q4 2025 | -$2.93 | -$1.98 |
| Q3 2025 | -$2.52 | -$1.87 |
| Q2 2025 | -$1.97 | -$1.43 |
AARD lost $3.21 per share over the past year, a bigger loss than the year before.
AARD Quarterly Revenue
AARD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$18.9M | -$7.5M |
| Q4 2025 | -$16.8M | -$9.1M |
| Q3 2025 | -$16.1M | -$12.2M |
| Q2 2025 | -$9.9M | -$5.6M |
| Q1 2025 | -$11.4M | -$9.2M |
| Q4 2024 | -$7.7M | -$6.6M |
| Q3 2024 | -$4M | -$2.4M |
AARD has burned cash in almost every quarter: −$62M over the past year, against −$27M the year before.
AARD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +30.3K shares |
| 1 year | +0.7% | +156K shares |
AARD has 22M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
AARD Net Leverage
AARD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AARD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.3 | Neutral |
| Stochastic | 6.0 | Oversold |
AARD's weekly RSI is 31 (neutral) and its Stochastic is 6 (oversold).
AARD PE vs Healthcare Sector
AARD has no meaningful PE right now: it lost money over the past year.
AARD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.00 | 49% below |
| 20 week MA | $4.95 | 69% below |
| 50 week MA | $7.05 | 78% below |
AARD is in a downtrend: it's below all three of its weekly moving averages, and 78% below its 50-week average.
AARD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $13.3 | $13.7 | +2.6% |
| 2026 YTD | $13.7 | $1.52 | -89% |
AARD has finished every year since 2025 higher, and it's down 89% so far in 2026.